Limited Recommendations for Routine Vaccinations During Pregnancy in the U.S.

A recent survey reveals that less than half of the adult population in the United States supports recommending some routine vaccines during pregnancy. While vaccinations such as the flu shot, Tdap, and RSV are still advised by the CDC for pregnant women to protect both mother and baby, public endorsement for these vaccines remains moderate. The study, conducted by the Annenberg Public Policy Center of the University of Pennsylvania, highlights a significant gap in public awareness and trust regarding immunizations during pregnancy.

The controversy surrounding COVID-19 vaccination during pregnancy was intensified in May when top U.S. health officials announced that the CDC's vaccination schedule would no longer endorse COVID-19 shots for healthy pregnant women and children, citing inadequate guidance. This shift came despite evidence indicating that pregnant women face increased risks from COVID-19, including higher mortality rates, and that vaccination offers protective benefits to newborns.

Major medical groups, including the American Academy of Pediatrics, challenged this decision through legal action, emphasizing that current data supports the safety and efficacy of COVID-19 vaccines during pregnancy. Experts stress that women who are pregnant or planning pregnancies should stay current on vaccinations, including flu, Tdap, RSV, and COVID-19, according to personalized medical advice.

Public skepticism about COVID-19 vaccination during pregnancy is also reflected in recent survey data, which shows only 38% of respondents would recommend it, with many uncertain about its safety. Knowledge about vaccine benefits, such as reducing hospitalization and pregnancy complications, remains uneven, especially among women of childbearing age. Despite this, health professionals underscore that vaccination during pregnancy remains a critical tool to protect maternal and fetal health.

Furthermore, the survey indicates low public willingness to endorse recommended vaccines like the flu, Tdap, and RSV for pregnant women this fall, with only about half suggesting they would recommend these vaccines. These findings highlight ongoing challenges in public health communication and trust, emphasizing the need for better education and reassurance about the safety and benefits of routine vaccinations during pregnancy.